Cerevance's experimental Parkinson's pill helps patients control symptoms longer in late-stage trial

Cerevance's experimental pill helped people with Parkinson's disease control their symptoms for a longer period each day in a late-stage trial, potentially giving patients a new option for managing the illness, The Times reports.

Detected & updated continuously · Source: Nebula